![Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma - European Journal of Cancer Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/686dd31c-2592-4b2d-906f-147f083e1aa9/gr1_lrg.jpg)
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma - European Journal of Cancer
![The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e46bcfb8-ae2b-4fff-9cdd-bf5166256c5d/gr1.jpg)
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative
![Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases. - Abstract - Europe PMC Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7247101/bin/SVDLD-36-157-g005.jpg)
Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases. - Abstract - Europe PMC
![Frontiers | High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization Frontiers | High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization](https://www.frontiersin.org/files/Articles/548602/fphar-11-00775-HTML/image_m/fphar-11-00775-g001.jpg)
Frontiers | High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization
![Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis - Kidney International Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2053325045/2060154640/gr1.jpg)
Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis - Kidney International
![High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy | British Journal of Cancer High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6603097/MediaObjects/41416_2006_Article_BF6603097_Fig1_HTML.gif)
High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy | British Journal of Cancer
![Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer | npj Breast Cancer Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-020-0171-1/MediaObjects/41523_2020_171_Fig1_HTML.png)
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer | npj Breast Cancer
![Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis - Kidney International Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/075d728e-3a3f-41fb-9b38-695bd0dcaf3c/fx1_lrg.jpg)